Multi-target TMS for Schizophrenia Negative Symptoms
This study is recruiting. It focuses on schizophrenia and currently lists participation information in China.
In Shanghai
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting. It focuses on schizophrenia and currently lists participation information in China.
In ShanghaiThis study is recruiting in China. It is testing Multicenter iTBS Neuromodulation for PTSD.
Multiple locations, including ShanghaiThis study is recruiting in the United States, in India, and in Serbia. It is testing lumateperone for depression in bipolarity.
Multiple locations, including DothanThis study is recruiting in the United States. It is testing LB-102 for Bipolarity.
Multiple locations, including BentonvilleThis study is recruiting in Germany. It is testing neurotransmitters and neuropeptides for schizophrenia.
In GermanyThis study is recruiting in Australia. It focuses on depression.
In AustraliaThis study is recruiting. It focuses on anxiety and currently lists participation information in the United States.
In AuroraThis study is recruiting. It focuses on PTSD and currently lists participation information in the United States.
In HoustonThis study is recruiting. It focuses on anxiety and currently lists participation information in Taiwan.
In KeelungThis study is recruiting. It focuses on ADHD and currently lists participation information in the United States.
In BaltimoreThis study is recruiting. It focuses on depression and currently lists participation information in China.
In HefeiThis study is recruiting. It focuses on PTSD and currently lists participation information in the United States.
In AlbuquerqueHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.